Screener
UroGen Pharma URGN Business Segments — Selling General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 65,884 | 20,665 | 112,704 | 38,589 |
| Operating expenses: | ||||
| Research and development expenses | 17,336 | 18,914 | 32,933 | 38,785 |
| Selling, general and administrative expenses | 48,437 | 43,199 | 99,923 | 78,166 |
| Operating income (loss) | 111 | (41,448) | (20,152) | (78,362) |
| Financing on prepaid forward obligation | (4,545) | (4,644) | (9,051) | (9,227) |
| Interest expense on long-term debt | (4,887) | (4,132) | (9,072) | (8,200) |
| Interest and other income, net | 599 | 1,299 | 1,207 | 3,413 |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's business segments — selling general and administrative expense?
- UroGen Pharma (URGN) reported business segments — selling general and administrative expense of $48.44M in Q2 2026.
- What does business segments — selling general and administrative expense mean?
- This metric represents the total operating costs incurred by the company's primary business segment to support commercialization, marketing, and general corporate administration. It captures expenditures related to the promotion and distribution of therapeutic products, as well as the overhead required to manage the organization's clinical and commercial operations. Monitoring this expense provides insight into the company's investment in scaling its market presence and the efficiency of its administrative infrastructure.
Ask your AI about UroGen Pharma's business segments — selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude